Literature DB >> 2462434

Molecular cloning of human neutrophil elastase.

D Farley1, G Salvesen, J Travis.   

Abstract

The human U937 cell line, a promonocyte-like leukemic line, has been shown to synthesize neutrophil elastase (Senior, R. M. et al. (1982) J. Clin. Invest. 69, 384-393). We have constructed a lambda gt11 cDNA library using RNA from this cell line and isolated a clone encoding part of the protein sequence of neutrophil elastase. Nucleotide sequencing indicates the clone encodes residues 108-243 (standard chymotrypsinogen numbering) of the enzyme, plus a hitherto unsuspected 20 residue-C-terminal extension of unusual structure. Comparison of the nucleotide and amino-acid sequence of elastase with the recently reported sequence of medullasin, a proteinase isolated from bone marrow, suggests they are identical.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462434

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  4 in total

1.  Neutrophil elastase and cathepsin G protein and messenger RNA expression in bone marrow from a patient with Chediak-Higashi syndrome.

Authors:  D Burnett; C J Ward; R A Stockley; R G Dalton; A J Cant; S Hoare; J Crocker
Journal:  Clin Mol Pathol       Date:  1995-02

2.  CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity.

Authors:  H A Pereira; W M Shafer; J Pohl; L E Martin; J K Spitznagel
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter.

Authors:  M Zimmer; R L Medcalf; T M Fink; C Mattmann; P Lichter; D E Jenne
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

4.  Elastase and cathepsin G from primed leukocytes cleave vascular endothelial cadherin in hemodialysis patients.

Authors:  Meital Cohen-Mazor; Rafi Mazor; Batya Kristal; Shifra Sela
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.